SOPHARMA AD - Conditional capital increase in connection with a resolution of the General Meeting of the holders of warrants with ISIN BG9200001212 held on 2 June 2023

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Conditonal capital increase.rar Conditional capital increase in connection with a resolution of the General Meeting of the holders of warrants with ISIN BG9200001212 held on 2 June 2023
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 36 / 2023

Date of issue: 2023-06-05

Short name of the issuer

SOPHARMA AD

Subject

Conditional capital increase in connection with a resolution of the General Meeting of the holders of warrants with ISIN BG9200001212 held on 2 June 2023

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Conditional capital increase in connection with a resolution of the General Meeting of the holders of warrants with ISIN BG9200001212 held on 2 June 2023

Annexes

File Description

Conditonal capital increase.rarConditonal capital increase.rar Conditional capital increase in connection with a resolution of the General Meeting of the holders of warrants with ISIN BG9200001212 held on 2 June 2023

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2023-06-05 Ognian Donev Executive Director